Literature DB >> 35544124

Outcomes of Acitretin Treatment for Refractory Multikinase Inhibitor-Induced Hand-Foot Skin Reaction.

Jordan T Said1,2, Sean Singer1,2, Lisa Iannattone1, Maxwell Sauder3,4, Nicole R LeBoeuf1,2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35544124      PMCID： PMC9096683          DOI： 10.1001/jamadermatol.2022.1425

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   11.816


× No keyword cloud information.
  6 in total

1.  Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer.

Authors:  Kazuo Kobayashi; Kazuyoshi Kawakami; Takashi Yokokawa; Takeshi Aoyama; Kenichi Suzuki; Takeru Wakatsuki; Mitsukuni Suenaga; Hitoshi Sato; Erika Sugiyama; Kensei Yamaguchi; Toshihiro Hama
Journal:  Oncology       Date:  2019-02-14       Impact factor: 2.935

2.  Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysis.

Authors:  Viswanath Reddy Belum; Shenhong Wu; Mario E Lacouture
Journal:  Invest New Drugs       Date:  2013-05-23       Impact factor: 3.850

Review 3.  An updated review of acitretin--a systemic retinoid for the treatment of psoriasis.

Authors:  Mei-Lin Pang; Jenny E Murase; John Koo
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-07       Impact factor: 4.481

4.  Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.

Authors:  C-H Yang; W-C Lin; C-K Chuang; Y-C Chang; S-T Pang; Y-C Lin; T-T Kuo; J-J Hsieh; J W C Chang
Journal:  Br J Dermatol       Date:  2007-12-06       Impact factor: 9.302

5.  Acitretin in the treatment of severe disorders of keratinization. Results of an open study.

Authors:  C Blanchet-Bardon; V Nazzaro; C Rognin; J M Geiger; A Puissant
Journal:  J Am Acad Dermatol       Date:  1991-06       Impact factor: 11.527

Review 6.  Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.

Authors:  B McLellan; F Ciardiello; M E Lacouture; S Segaert; E Van Cutsem
Journal:  Ann Oncol       Date:  2015-06-01       Impact factor: 32.976
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.